Diabetes mellitus and outcome after primary coronary angioplasty for acute myocardial infarction: lessons from the GUSTO-IIb angioplasty substudy
David Hasdai, MDa,
Christopher B. Granger, MD, FACC*,
S. Sanjay Srivatsa, MBBChir, FACC
,
Douglas A. Criger, MS*,
Stephen G. Ellis, MD, FACC
,
Robert M. Califf, MD, FACC*,
Eric J. Topol, MD, FACC
and
David R. Holmes, Jr., MD, FACC
a Rabin Medical Center, Petah Tikva, Israel
* Duke Clinical Research Institute, Durham, North Carolina, USA
Mayo Clinic, Rochester, Minnesota, USA
Cleveland Clinic Foundation, Cleveland, Ohio, USA

View larger version (11K):
[in a new window]
|
Figure 1 Kaplan-Meier curves depicting the estimated survival free of death or reinfarction for diabetic and nondiabetic patients within six months of follow-up after (Re) MI. (Re) MI = reinfarction.
|
|

View larger version (12K):
[in a new window]
|
Figure 2 Kaplan-Meier curves depicting the estimated survival for diabetic and nondiabetic patients within 12 months of follow-up after (Re) MI. (Re) MI = reinfarction.
|
|
Copyright © 2000 by the American College of Cardiology Foundation.